Funded startups/Aeovian Pharmaceuticals, Inc.

Aeovian Pharmaceuticals, Inc.

SEC filing

Pharmaceuticals · Berkeley, CA

Form D on EDGAR

Amount raised$55Msold at filing

Total offering$55M

Investors in the raise13count reported to the SEC

FiledDec 22, 2025first sale Nov 18, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

John J. KincaidExecutive Officer

Youssef J. BennaniDirector

Themasap J. KhanDirector

Nils J. ReggeDirector

Davis J. RymanExecutive Officer

William J. GreeneDirector

Micah J. ZajicExecutive Officer

Lars J. EkmanDirector

Justin J. GoverDirector

Allison J. HulmeExecutive Officer, Director

Richard J. GasterDirector

Executive officers, directors and promoters as listed on the Form D.